Tak Paul Peter - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 17, 2024, Tak Paul Peter's relationship to Candel Therapeutics, Inc. (CADL) is Director,Officer (Chief Executive Officer), and currently has 330,735 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CADL insiders.
Data Source: SEC.
Tak Paul Peter - Insider Non-Derivative Transactions of CADL Common Stock
Tak Paul Peter - Insider Non-Derivative Transactions at CADL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 18, 2024 | Sell -- (Common Stock) | 22528 | 6.47 | 330735 |
| Jul 12, 2024 | Sell -- (Common Stock) | 20293 | 5.97 | 353263 |
| Nov 29, 2023 | F -- (Common Stock) | 43443 | 0.9 | 373556 |
| Nov 27, 2023 | Acquisition -- (Common Stock) | 180108 | 0 | 416999 |